Monogram Expects to Report 2008 Revenues of $62M | GenomeWeb

NEW YORK (GenomeWeb News) – Monogram Biosciences said last week that it expects to report fiscal 2008 revenues of approximately $62 million, an increase of 44 percent over 2007 revenues of $43.2 million.

The South San Francisco, Calif.-based firm said that among the contributors to its revenue increase for the year were sales of $16 million from its Trofile assay, which is used to select HIV patients for CCR5 agonists, such as Pfizer's maraviroc (Selzentry).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.